Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Inhibrx Biosciences, Inc. - Common Stock (NQ:INBX)

53.76 +25.40 (+89.56%)
Streaming Delayed Price Updated: 12:17 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,124,328
Open 49.13
Bid (Size) 53.52 (2)
Ask (Size) 54.00 (1)
Prev. Close 28.36
Today's Range 46.01 - 55.50
52wk Range 10.80 - 39.27
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Inhibrx Stock Soars on Breakthrough Chondrosarcoma Trial Results: A New Dawn for Rare Cancer Treatment
San Diego, CA – October 24, 2025 – Inhibrx (NASDAQ: INBX) shares have surged dramatically, skyrocketing over 70% in pre-market and after-hours trading, following the announcement of overwhelmingly... 
Via MarketMinute
Ford, Inhibrx Biosciences, Comfort Systems, Western Union And Other Big Stocks Moving Higher On Friday
 
Via Benzinga

Performance

YTD
+252.5%
+252.5%
1 Month
+86.0%
+86.0%
3 Month
+133.0%
+133.0%
6 Month
+348.7%
+348.7%
1 Year
+241.1%
+241.1%

More News

Read More
Which stocks are gapping on Friday?
Via Chartmill
Why Is INBX Stock Rising Today?
Via Stocktwits
INBX Stock Earnings: Inhibrx Beats EPS for Q1 2024
Via InvestorPlace
Get insights into the top gainers and losers of Friday's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Are Inhibrx Biosciences Shares Soaring 76% After Hours?
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Get insights into the top gainers and losers of Thursday's after-hours session.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Inhibrx Biosciences Beats Earnings
Via The Motley Fool
Topics Intellectual Property
Around $2M Bet On Franklin Resources? Check Out These 4 Stocks Executives Are Buying
Via Benzinga
Over $7M Bet On This Health Care Stock? Check Out These 3 Stocks Executives Are Buying
Via Benzinga
INBX Stock Earnings: Inhibrx Biosciences Beats EPS for Q2 2024
Via InvestorPlace
Top 4 Health Care Stocks That Are Preparing To Pump This Month
Via Benzinga
INHIBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inhibrx, Inc. - INBX
From Kahn Swick & Foti, LLC
Via Business Wire
The NVDA Earnings Effect And What It Means For The Current Market Momentum
Via Talk Markets
Topics Stocks
Is The Stock Market Ready To Plunge? The Warning Signs Are Here...
Via Talk Markets
INHIBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inhibrx, Inc. - INBX
From Kahn Swick & Foti, LLC
Via Business Wire
Sanofi Barrels Into Liver Disease Space With $1.7 Billion Takeover Of Inhibrx
Via Investor's Business Daily
INBX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Inhibrx, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
French Drugmaker Sanofi Agrees To Buy Inhibrx's Candidate For Rare Genetic Indication, For About $2.2B
Via Benzinga
Olympic Sponsor Sanofi Makes Major Play In Rare Disease Arena $2.2 Billion Acquisition Of Inhibrx Project
Via Benzinga

Frequently Asked Questions

Is Inhibrx Biosciences, Inc. - Common Stock publicly traded?
Yes, Inhibrx Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Inhibrx Biosciences, Inc. - Common Stock trade on?
Inhibrx Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Inhibrx Biosciences, Inc. - Common Stock?
The ticker symbol for Inhibrx Biosciences, Inc. - Common Stock is INBX on the Nasdaq Stock Market
What is the current price of Inhibrx Biosciences, Inc. - Common Stock?
The current price of Inhibrx Biosciences, Inc. - Common Stock is 53.76
When was Inhibrx Biosciences, Inc. - Common Stock last traded?
The last trade of Inhibrx Biosciences, Inc. - Common Stock was at 10/24/25 12:17 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.